SOURCE: I-many

I-many

April 16, 2010 08:34 ET

Another Top Pharmaceutical Leader Selects I-many

Leading Research-Based Pharmaceutical Company Chooses I-many for a New Contract Administration, Rebate and Chargeback Processing Platform

PHILADELPHIA, PA--(Marketwire - April 16, 2010) -  I-many, the leading provider of Contract Management and Revenue Optimization software, announced today a leading pharmaceutical company, focused on the treatment of respiratory and central nervous system disorders, has selected the following I-many® ContractSphere® products: I-many® CARS®, I-many® CARS® BI and I-many® Validata®.

After a thorough evaluation of competitive contract management solutions, this research-based pharmaceutical leader selected the I-many solutions to manage their commercial contracts due to the superior end-to end contracting management, analysis, and performance capabilities. Moreover, I-many was the only company to offer a proven in-house prescription validation tool, I-many Validata, which can validate and reconcile incoming sales data received as part of the commercial managed care and Medicare Part D contracting process.

"We are proud that so many leaders in the life sciences industry turn to I-many for their enterprise contracting needs," said P. Kevin Kilroy, President and CEO of I-many. "This win further shows our commitment to the industry and the fact that more global Life Science enterprises select I-many to manage their contracting processes."

I-many's comprehensive solutions enable organizations to manage the entire contract lifecycle, from pre-contract processes and contract management to active compliance, contract optimization, demand channel visibility and control; resulting in greater levels of insight into contract performance, improved profitability, and measurable return on investments.

About I-many
I-many is the leading provider of contract management and revenue optimization software and services for the enterprise within the life sciences industry as well as other sectors that must manage complex contractual relationships integral to their core business. With 21 of the top 25 life sciences companies and hundreds of organizations across 21 industries worldwide, I-many enables businesses to manage the entire contract lifecycle, from pre-contract processes and contract management to active compliance, contract optimization, demand channel visibility and control. The result is a comprehensive solution that provides greater levels of insight into contract performance and regulatory compliance, allowing companies to improve profitability and achieve a significant measurable return on investment within a very short timeframe. For more information, please visit www.imany.com.

Contact Information

  • Press Contact:
    I-many
    Jerry Inman
    +1.215.344.1900
    Email Contact